173 related articles for article (PubMed ID: 17376576)
1. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.
Nishikawa H; Inoue T; Masui T; Izumi T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):926-31. PubMed ID: 17376576
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4.
Nishikawa H; Inoue T; Masui T; Izumi T; Nakagawa S; Koyama T
Psychiatry Clin Neurosci; 2008 Oct; 62(5):591-6. PubMed ID: 18950380
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress.
Nishitsuji K; To H; Shimizu T; Yanase Y; Yamada T; Hara C; Mine K; Higuchi S
Eur Neuropsychopharmacol; 2006 Jul; 16(5):376-82. PubMed ID: 16406508
[TBL] [Abstract][Full Text] [Related]
4. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats.
Nishikawa H; Inoue T; Izumi T; Koyama T
Eur Neuropsychopharmacol; 2007 Oct; 17(10):643-50. PubMed ID: 17368862
[TBL] [Abstract][Full Text] [Related]
6. Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine.
Miller LG; Thompson ML; Byrnes JJ; Greenblatt DJ; Shemer A
J Clin Psychopharmacol; 1992 Oct; 12(5):341-5. PubMed ID: 1362206
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
8. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
Evans SM; Troisi JR; Griffiths RR
J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
[TBL] [Abstract][Full Text] [Related]
9. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
Kakui N; Yokoyama F; Yamauchi M; Kitamura K; Imanishi T; Inoue T; Koyama T
Pharmacol Biochem Behav; 2009 May; 92(3):393-8. PubMed ID: 19167420
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation.
Saito Y; Matsumoto M; Yanagawa Y; Hiraide S; Inoue S; Kubo Y; Shimamura K; Togashi H
Synapse; 2013 Apr; 67(4):161-70. PubMed ID: 23152167
[TBL] [Abstract][Full Text] [Related]
12. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala.
Li X; Inoue T; Abekawa T; Weng S; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2006 Feb; 532(1-2):74-80. PubMed ID: 16460727
[TBL] [Abstract][Full Text] [Related]
14. Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats.
Verleye M; Gillardin JM
Physiol Behav; 2004 Oct; 82(5):891-7. PubMed ID: 15451655
[TBL] [Abstract][Full Text] [Related]
15. SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats.
Nishikawa H; Inoue T; Izumi T; Nakagawa S; Koyama T
Behav Pharmacol; 2010 Sep; 21(5-6):576-9. PubMed ID: 20613495
[TBL] [Abstract][Full Text] [Related]
16. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
Maki Y
Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
[TBL] [Abstract][Full Text] [Related]
17. [The characteristics of the pharmacological action of buspirone].
Dzhagatspanian IA; Asrian AB
Eksp Klin Farmakol; 1994; 57(1):5-8. PubMed ID: 8142866
[TBL] [Abstract][Full Text] [Related]
18. Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.
Wisłowska-Stanek A; Zienowicz M; Lehner M; Taracha E; Bidziński A; Maciejak P; Skórzewska A; Szyndler J; Płaźnik A
Neurosci Lett; 2005 Dec; 389(2):115-20. PubMed ID: 16095819
[TBL] [Abstract][Full Text] [Related]
19. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
Sasa M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):53-9. PubMed ID: 9201724
[TBL] [Abstract][Full Text] [Related]
20. Effects of tandospirone in three behavioral tests for anxiolytics.
Pollard GT; Nanry KP; Howard JL
Eur J Pharmacol; 1992 Oct; 221(2-3):297-305. PubMed ID: 1358655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
